Q&A: Forbion Capital Partners' Sander Slootweg
Life-sciences-focused venture firm Forbion Capital Partners recently held a €360m final close for its fourth flagship fund, surpassing its initial hard-cap of €350m. Managing partner Sander Slootweg speaks to Francesca Veronesi about the fundraising process, the firm's 'build' strategy and the European life sciences venture market
More on Benelux
Volpi backs Mansystems with €20m
Volpi closed its debut fund on €185m, with the expectation of doing six platform investments
HPE Growth leads €35m series-B for WeTransfer
Existing investor Highland Europe has also taken part in the latest funding round
Triton opens office in Amsterdam, makes new hire
Triton has opened an office in the Netherlands and hired van de Linde from Bain Capital
Steadfast buys Koop Group
Fifth platform investment from Steadfast Capital Fund IV, which held a final close on €297m
Latest News
Nordwind's B2B Media Group bolts on Aumago
Nordwind Capital's portfolio company B2B Media Group has acquired a digital marketing agency
Creandum promotes Specht to principal
In his new role, Specht will lead deals of all sizes across Europe and the US
Volpi backs Mansystems with €20m
Volpi closed its debut fund on €185m, with the expectation of doing six platform investments
Beech Tree invests in Avid
Insurance intermediary Avid Insurance is Beech Tree's seventh platform acquisition